NCT06622928

Brief Summary

The acute effect of hemodialysis (HD) on left ventricular mechanics has been evaluated in several studies, however their results are not uniform. Eventually, the heart and the arterial system behave as an interconnected system and not as isolated structures; thus, the evaluation of the interaction of cardiac contractility with the arterial system would provide a more comprehensive understanding of the cardiovascular function and cardiac energetics. However, there have not been any studies demonstrating changes in terms of volumes, contractility, intraventricular pressure gradients distribution, and vascular properties in response to changes in loading conditions and their impact on the outcome. With these concepts in mind, we aim to evaluate the effect of volume changes induced by HD on ventriculo-arterial coupling (VAC) computed from speckle-tracking echocardiography. In particular, we seek to study patients with end-stage renal disease (ESRD) to assess:

  1. 1.VAC parameters before and after the hemodialysis session;
  2. 2.The value of VAC parameters in predicting adverse outcome

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
384

participants targeted

Target at P75+ for all trials

Timeline
6mo left

Started Oct 2024

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress77%
Oct 2024Nov 2026

First Submitted

Initial submission to the registry

September 29, 2024

Completed
2 days until next milestone

Study Start

First participant enrolled

October 1, 2024

Completed
1 day until next milestone

First Posted

Study publicly available on registry

October 2, 2024

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 30, 2026

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2026

Expected
Last Updated

October 2, 2024

Status Verified

September 1, 2024

Enrollment Period

1.5 years

First QC Date

September 29, 2024

Last Update Submit

September 29, 2024

Conditions

Keywords

hemodialysisend-stage renal diseaseventriculo-arterial couplingadvanced echocardiographycardiac ultrasound

Outcome Measures

Primary Outcomes (1)

  • Evaluation of Interdialytic Changes in Ventricular-Arterial Coupling (VAC) and Its Prognostic Value in Patients Undergoing Regular Hemodialysis

    1 year

Study Arms (1)

End-Stage Renal Disease Patients on Hemodialysis

Patients with end-stage renal disease (ESRD) undergoing regular hemodialysis, recruited based on specific inclusion and exclusion criteria. Inclusion criteria include patients aged 18 or older, receiving a standard renal replacement therapy of three dialysis sessions per week, with a dialysis history of at least 3 months and dialysis adequacy (Kt/V \>1.2). Exclusion criteria include patients with a history of kidney transplantation, recent myocardial infarction or stroke, severe heart failure, chronic atrial fibrillation, obesity (BMI \>40 kg/m²), and malignancy. Patients will undergo echocardiographic evaluations before and after dialysis, with a focus on left ventricular function and ventriculo-arterial coupling (VAC) using speckle-tracking echocardiography and pressure-volume loop analysis.

Diagnostic Test: Echocardiogram

Interventions

EchocardiogramDIAGNOSTIC_TEST

Echocardiographic Assessments: Pre-Hemodialysis Echocardiography: Before each hemodialysis session, echocardiograms will be performed to evaluate cardiac function and gather baseline data on ventriculo-arterial coupling (VAC) parameters. This will include recording three apical echocardiographic views (4-chamber, 2-chamber, and 3-chamber) by a trained sonographer. Post-Hemodialysis Echocardiography: Following the completion of the hemodialysis session, echocardiographic assessments will be repeated to measure changes in VAC parameters and other relevant cardiac metrics.

End-Stage Renal Disease Patients on Hemodialysis

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study population will consist of 384 patients with end-stage renal disease (ESRD) recruited from the B.B. NURA Center of Efferent Therapy and Hemodialysis in Astana. This center, operational since 1988, provides comprehensive hemodialysis services, including 24/7 emergency care for patients requiring renal replacement therapy.

You may qualify if:

  • years or older;
  • Standard renal replacement schedule with 3 dialysis sessions per week;
  • Dialysis vintage of at least 3 months;
  • Dialysis adequacy with single-pool Kt/V \>1.2

You may not qualify if:

  • Previous kidney transplantation
  • Myocardial infarction, unstable angina or stroke during the previous 6 months;
  • Severe stage III to IV congestive heart failure according to the NYHA classification;
  • Chronic atrial fibrillation or other known arrhythmia;
  • History of non-adherence to the prescribed weekly dialysis schedule in the previous month;
  • Body mass index \>40 Kg/m2; or
  • History of malignancy or other clinical conditions associated with very poor prognosis.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Nazarbayev University School of Medicine

Astana, 010000, Kazakhstan

Location

Related Publications (6)

  • Bansal N, Zelnick L, Bhat Z, Dobre M, He J, Lash J, Jaar B, Mehta R, Raj D, Rincon-Choles H, Saunders M, Schrauben S, Weir M, Wright J, Go AS; CRIC Study Investigators. Burden and Outcomes of Heart Failure Hospitalizations in Adults With Chronic Kidney Disease. J Am Coll Cardiol. 2019 Jun 4;73(21):2691-2700. doi: 10.1016/j.jacc.2019.02.071.

    PMID: 31146814BACKGROUND
  • Iseki K, Fukiyama K. Long-term prognosis and incidence of acute myocardial infarction in patients on chronic hemodialysis. The Okinawa Dialysis Study Group. Am J Kidney Dis. 2000 Oct;36(4):820-5. doi: 10.1053/ajkd.2000.17676.

    PMID: 11007686BACKGROUND
  • Inuzuka R, Kass DA, Senzaki H. Novel, single-beat approach for determining both end-systolic pressure-dimension relationship and preload recruitable stroke work. Open Heart. 2016 Jun 15;3(1):e000451. doi: 10.1136/openhrt-2016-000451. eCollection 2016.

    PMID: 27347424BACKGROUND
  • Zuo ML, Chen QY, Pu L, Shi L, Wu D, Li H, Luo X, Yin LX, Siu CW, Hong DQ, Gan H. Impact of Hemodialysis on Left Ventricular-Arterial Coupling in End-Stage Renal Disease Patients. Blood Purif. 2023;52(7-8):702-711. doi: 10.1159/000531188. Epub 2023 Aug 14.

    PMID: 37579725BACKGROUND
  • Sasso L, Capuano A, Minco M, Paglia A, Pirozzi F, Memoli B, Carlomagno G, Petretta M, Bonaduce D. Hemodialysis does not affect ventricular-arterial coupling beyond the reduction of blood pressure and preload. Int J Cardiol. 2013 Sep 30;168(2):1553-4. doi: 10.1016/j.ijcard.2012.12.024. Epub 2013 Feb 27. No abstract available.

    PMID: 23453441BACKGROUND
  • Salustri A, Tonti G, Pedrizzetti G, Zhankorazova A, Khamitova Z, Toktarbay B, Jumadilova D, Khvan M, Galiyeva D, Bekbossynova M, Mukarov M, Kokoshko A, Gaipov A. Intradialytic Changes and Prognostic Value of Ventriculo-Arterial Coupling in Patients With End-Stage Renal Disease: Protocol for an Observational Prospective Trial. JMIR Res Protoc. 2025 Jun 23;14:e71948. doi: 10.2196/71948.

MeSH Terms

Conditions

Kidney Failure, Chronic

Interventions

Echocardiography

Condition Hierarchy (Ancestors)

Renal Insufficiency, ChronicRenal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Cardiac Imaging TechniquesDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosisUltrasonographyHeart Function TestsDiagnostic Techniques, Cardiovascular

Study Officials

  • Alessandro Salustri, MD, PhD

    Nazarbayev University School of Medicine

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Alessandro Salustri, MD, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 29, 2024

First Posted

October 2, 2024

Study Start

October 1, 2024

Primary Completion

March 30, 2026

Study Completion (Estimated)

November 1, 2026

Last Updated

October 2, 2024

Record last verified: 2024-09

Locations